These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 38075202)

  • 21. Dynamic m6A-ncRNAs association and their impact on cancer pathogenesis, immune regulation and therapeutic response.
    Yan Y; Peng J; Liang Q; Ren X; Cai Y; Peng B; Chen X; Wang X; Yi Q; Xu Z
    Genes Dis; 2023 Jan; 10(1):135-150. PubMed ID: 37013031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging role of interaction between m6A and main ncRNAs in gastrointestinal (GI) cancers.
    Xu Y; Yu X; Guo W; He Y
    Front Immunol; 2023; 14():1129298. PubMed ID: 36875073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
    Qin S; Mao Y; Wang H; Duan Y; Zhao L
    Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer.
    Lu M; Zhan H; Liu B; Li D; Li W; Chen X; Zhou X
    EPMA J; 2021 Dec; 12(4):589-604. PubMed ID: 34950253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic modification of m
    Wang Y; Wang Y; Patel H; Chen J; Wang J; Chen ZS; Wang H
    Mol Cancer; 2023 Jun; 22(1):102. PubMed ID: 37391814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of m
    Tabnak P; Ghasemi Y; Natami M; Khorram R; Ebrahimnezhad M
    Biomed Pharmacother; 2023 Jan; 157():114023. PubMed ID: 36403567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance.
    Chen Z; Hu Y; Jin L; Yang F; Ding H; Zhang L; Li L; Pan T
    Front Pharmacol; 2022; 13():873030. PubMed ID: 35462896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer.
    Cusenza VY; Tameni A; Neri A; Frazzi R
    Front Oncol; 2023; 13():1063636. PubMed ID: 36969033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
    Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
    Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Interaction Between N
    Yao L; Man CF; He R; He L; Huang JB; Xiang SY; Dai Z; Wang XY; Fan Y
    Front Oncol; 2021; 11():784127. PubMed ID: 35070987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
    Lin H; Wang Y; Wang P; Long F; Wang T
    Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel insights into the interplay between m
    Yi YC; Chen XY; Zhang J; Zhu JS
    Mol Cancer; 2020 Aug; 19(1):121. PubMed ID: 32767982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.
    Dai XY; Shi L; Li Z; Yang HY; Wei JF; Ding Q
    Front Oncol; 2021; 11():635329. PubMed ID: 33928028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment.
    Wang D; Han Y; Peng L; Huang T; He X; Wang J; Ou C
    Int J Biol Sci; 2023; 19(7):2198-2219. PubMed ID: 37151887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The significance of N6-methyladenosine-modified non-coding RNAs in different disorders.
    Ghafouri-Fard S; Shoorei H; Hussen BM; Dong P; Zhai T; Taheri M; Samadian M
    Eur J Pharmacol; 2023 May; 946():175644. PubMed ID: 36921707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m
    Sun CY; Cao D; Du BB; Chen CW; Liu D
    Int J Biol Sci; 2022; 18(7):2744-2758. PubMed ID: 35541906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment.
    Zhang Y; Zhan L; Li J; Jiang X; Yin L
    Aging (Albany NY); 2023 May; 15(9):3857-3889. PubMed ID: 37178254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N
    Li J; Zhang H; Wang H
    Comput Struct Biotechnol J; 2022; 20():6578-6585. PubMed ID: 36467585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of N
    Song D; Hou J; Wu J; Wang J
    Front Cardiovasc Med; 2021; 8():659628. PubMed ID: 34026872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The crucial roles of N
    Fang Z; Hu Y; Hu J; Huang Y; Zheng S; Guo C
    Cell Biosci; 2021 Apr; 11(1):72. PubMed ID: 33836813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.